Assessment of Exercise Capacity of Individuals with Long COVID: A Cross-sectional Study.


Journal

The Israel Medical Association journal : IMAJ
ISSN: 1565-1088
Titre abrégé: Isr Med Assoc J
Pays: Israel
ID NLM: 100930740

Informations de publication

Date de publication:
Feb 2023
Historique:
entrez: 26 2 2023
pubmed: 27 2 2023
medline: 3 3 2023
Statut: ppublish

Résumé

Clinical investigations of long-term effects of coronavirus disease 2019 (COVID-19) are rarely translated to objective findings. To assess the functional capacity of individuals reported on deconditioning that hampered their return to their pre-COVID routine. Assessment included the 6-minute walk test (6MWT) and the 30-second sit-to-stand test (30-STST). We compared the expected and observed scores using the Wilcoxon signed-rank test. Predictors of test scores were identified using linear regression models. We included 49 individuals, of whom 38 (77.6%) were recovering from mild COVID-19. Twenty-seven (55.1%) individuals had a 6MWT score lower than 80% of expected. The average 6MWT scores were 129.5 ± 121.2 meters and 12.2 ± 5.0 repeats lower than expected scores, respectively (P < 0.001 for both). The 6MWT score was 107.3 meters lower for individuals with severe COVID-19 (P = 0.013) and rose by 2.7 meters per each 1% increase in the diffusing capacity of carbon monoxide (P = 0.007). The 30-STST score was 3.0 repeats lower for individuals who reported moderate to severe myalgia (P = 0.038). Individuals with long COVID who report on deconditioning exhibit significantly decreased physical capacity, even following mild acute illness. Risk factors include severe COVID-19 and impaired diffusing capacity or myalgia during recovery.

Sections du résumé

BACKGROUND BACKGROUND
Clinical investigations of long-term effects of coronavirus disease 2019 (COVID-19) are rarely translated to objective findings.
OBJECTIVES OBJECTIVE
To assess the functional capacity of individuals reported on deconditioning that hampered their return to their pre-COVID routine.
METHODS METHODS
Assessment included the 6-minute walk test (6MWT) and the 30-second sit-to-stand test (30-STST). We compared the expected and observed scores using the Wilcoxon signed-rank test. Predictors of test scores were identified using linear regression models.
RESULTS RESULTS
We included 49 individuals, of whom 38 (77.6%) were recovering from mild COVID-19. Twenty-seven (55.1%) individuals had a 6MWT score lower than 80% of expected. The average 6MWT scores were 129.5 ± 121.2 meters and 12.2 ± 5.0 repeats lower than expected scores, respectively (P < 0.001 for both). The 6MWT score was 107.3 meters lower for individuals with severe COVID-19 (P = 0.013) and rose by 2.7 meters per each 1% increase in the diffusing capacity of carbon monoxide (P = 0.007). The 30-STST score was 3.0 repeats lower for individuals who reported moderate to severe myalgia (P = 0.038).
CONCLUSIONS CONCLUSIONS
Individuals with long COVID who report on deconditioning exhibit significantly decreased physical capacity, even following mild acute illness. Risk factors include severe COVID-19 and impaired diffusing capacity or myalgia during recovery.

Identifiants

pubmed: 36841973

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-87

Auteurs

Dana Yelin (D)

Department of COVID Recovery Clinic, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Faculty of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Ran Levi (R)

Department of Physical Therapy, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.

Chinanit Babu (C)

Department of Physical Therapy, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.

Roi Moshe (R)

Department of Physical Therapy, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.

Dorit Shitenberg (D)

Department of COVID Recovery Clinic, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Department of Pulmonary Medicine, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.

Alaa Atamna (A)

Department of COVID Recovery Clinic, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Department of Infectious Diseases, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Faculty of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Ori Tishler (O)

Department of COVID Recovery Clinic, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Department of Internal Medicine F, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.

Tanya Babich (T)

Department of Internal Medicine F, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Department of Research Authority, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Faculty of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Irit Shapira-Lichter (I)

Department of Functional MRI Center, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Faculty of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, Sagol School of Neuroscience, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Donna Abecasis (D)

Department of Functional MRI Center, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.

Nira Cohen Zubary (N)

Department of Physical Therapy, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.

Leonard Leibovici (L)

Department of Functional MRI Center, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Faculty of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Dafna Yahav (D)

Department of Infectious Diseases, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Faculty of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Ili Margalit (I)

Department of COVID Recovery Clinic, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Department of Infectious Diseases, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel, Faculty of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH